JP2025517106A5 - - Google Patents
Info
- Publication number
- JP2025517106A5 JP2025517106A5 JP2024563976A JP2024563976A JP2025517106A5 JP 2025517106 A5 JP2025517106 A5 JP 2025517106A5 JP 2024563976 A JP2024563976 A JP 2024563976A JP 2024563976 A JP2024563976 A JP 2024563976A JP 2025517106 A5 JP2025517106 A5 JP 2025517106A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- pharmaceutically acceptable
- independently selected
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/089986 | 2022-04-28 | ||
| CN2022089986 | 2022-04-28 | ||
| PCT/CN2023/077272 WO2023207283A1 (en) | 2022-04-28 | 2023-02-20 | Compounds as parp1 inhibitiors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025517106A JP2025517106A (ja) | 2025-06-03 |
| JP2025517106A5 true JP2025517106A5 (cg-RX-API-DMAC10.html) | 2026-02-27 |
Family
ID=88517229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024563976A Pending JP2025517106A (ja) | 2022-04-28 | 2023-02-20 | Parp1阻害剤としての化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250289814A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4514795A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025517106A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20250033148A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119487027A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023207283A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120081844A (zh) | 2022-01-21 | 2025-06-03 | 新特拉有限公司 | Parp1抑制剂及其用途 |
| US20250214980A1 (en) | 2022-03-14 | 2025-07-03 | Slap Pharmaceuticals Llc | Multicyclic compounds |
| PT4497438T (pt) | 2022-04-28 | 2025-10-31 | Xinthera Inc C/O Gilead Sciences Inc | Inibidores tricíclicos da parp1 e suas utilizações |
| TW202416977A (zh) * | 2022-09-30 | 2024-05-01 | 大陸商中國醫藥研究開發中心有限公司 | 含氮雜環類化合物及其醫藥用途 |
| KR20260100685A (ko) * | 2023-10-23 | 2026-06-30 | 길리애드 사이언시즈, 인코포레이티드 | Parp1 저해제 및 이의 용도 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI0906294T1 (en) * | 1996-05-29 | 2003-04-30 | Warner-Lambert Company | Benzoxazinone dopamine d4 receptor antagonists |
| GB0227240D0 (en) * | 2002-11-21 | 2002-12-31 | Glaxo Group Ltd | Compounds |
| EP1758895A1 (en) * | 2004-06-17 | 2007-03-07 | Wyeth a Corporation of the State of Delaware | Gonadotropin releasing hormone receptor antagonists |
| WO2009053373A1 (en) * | 2007-10-26 | 2009-04-30 | Janssen Pharmaceutica Nv | Quinolinone derivatives as parp inhibitors |
| AR070221A1 (es) | 2008-01-23 | 2010-03-25 | Astrazeneca Ab | Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas. |
| EP2415767B1 (en) * | 2009-03-27 | 2014-09-03 | Takeda Pharmaceutical Company Limited | Poly (ADP-ribose) Polymerase (PARP) Inhibitors |
| TWI837403B (zh) * | 2019-07-19 | 2024-04-01 | 瑞典商阿斯特捷利康公司 | 化學化合物 |
| TW202309025A (zh) * | 2021-04-19 | 2023-03-01 | 美商辛瑟拉股份有限公司 | Parp1抑制劑及其用途 |
| WO2022228387A1 (en) | 2021-04-26 | 2022-11-03 | Fochon Biosciences, Ltd. | Compounds as parp inhibitors |
| TWI876212B (zh) | 2021-10-01 | 2025-03-11 | 美商辛瑟拉股份有限公司 | 吖丁啶及吡咯啶parp1抑制劑及其用途 |
| TW202416977A (zh) | 2022-09-30 | 2024-05-01 | 大陸商中國醫藥研究開發中心有限公司 | 含氮雜環類化合物及其醫藥用途 |
-
2023
- 2023-02-20 EP EP23794719.7A patent/EP4514795A4/en active Pending
- 2023-02-20 KR KR1020247039613A patent/KR20250033148A/ko active Pending
- 2023-02-20 JP JP2024563976A patent/JP2025517106A/ja active Pending
- 2023-02-20 WO PCT/CN2023/077272 patent/WO2023207283A1/en not_active Ceased
- 2023-02-20 US US18/861,016 patent/US20250289814A1/en active Pending
- 2023-02-20 CN CN202380050136.0A patent/CN119487027A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540228A5 (cg-RX-API-DMAC10.html) | ||
| US6762204B2 (en) | Taxol enhancer compounds | |
| EP2799437B1 (en) | Quinoline and cinnoline derivatives and use thereof | |
| KR102796209B1 (ko) | 키나아제 억제제로서의 시클릭 이미노피리미딘 유도체 | |
| TWI773730B (zh) | 治療性樹枝狀聚合物 | |
| RU2005100842A (ru) | Производные 8-гидроксихинолина | |
| JP2020527173A5 (cg-RX-API-DMAC10.html) | ||
| CN107382966B (zh) | 一类荜茇酰胺-川芎嗪杂合物、制备方法及医药用途 | |
| JP2017534657A (ja) | 新型シチジン誘導体およびその適用 | |
| AU2019331665A1 (en) | Heterocyclic compounds as AHR modulators | |
| JP2018529643A5 (cg-RX-API-DMAC10.html) | ||
| CN101426770A (zh) | 用作edg-1拮抗剂的咪唑衍生物 | |
| CN110156783B (zh) | 作为pi3k/mtor抑制剂的嘧啶基取代的稠合喹啉化合物 | |
| CN103113386B (zh) | 氮杂环取代二氢青蒿素衍生物及其应用 | |
| CA3179325A1 (en) | Kinase inhibitors and uses thereof | |
| CN103476769B (zh) | 抗癌剂 | |
| JP2022552019A5 (cg-RX-API-DMAC10.html) | ||
| CN104250253A (zh) | 取代四氢化萘酰胺类化合物及其药学上可接受的盐及制备方法和应用 | |
| WO1996028447A1 (en) | Pyrrolocarbazole derivatives | |
| CN106946868A (zh) | 一氧化氮供体型香豆素衍生物、其制备方法及医药用途 | |
| JP5701387B2 (ja) | ベルバミンのジカルボキシミド誘導体、その調製方法及び使用 | |
| CN108707145B (zh) | 含五元杂环结构的喹啉类化合物及其制备和应用 | |
| JP2021534084A5 (cg-RX-API-DMAC10.html) | ||
| JP7302090B2 (ja) | ベンゾフラン系n-アシルヒドラゾン誘導体およびそれを含む薬学的組成物 | |
| CN102617502A (zh) | 一类苯并噁唑衍生物及其医药应用 |